CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Clinical trials for CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common vitamin help fix low blood counts?
Disease control Recruiting nowThis phase 2 trial is testing whether two dietary supplements—nicotinamide riboside (a vitamin B3 derivative) and pterostilbene (a plant compound)—can safely improve low blood counts in people with lower-risk myelodysplastic syndrome (MDS) or high-risk clonal cytopenia of undeter…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to boost blood counts in rare pre-leukemia condition
Disease control Recruiting nowThis study tests whether enasidenib, a drug that blocks a faulty IDH2 protein, can safely improve blood cell counts in people with clonal cytopenia of undetermined significance (CCUS). CCUS causes low blood counts and raises the risk of blood cancers. The trial enrolls 15 adults …
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a cancer drug stop a blood disorder before it turns deadly?
Disease control Recruiting nowThis pilot study is for people with high-risk CCUS, a blood condition that can lead to cancer. Participants can choose to be watched or take an oral drug called Inqovi (decitabine/cedazuridine). The goal is to see if early treatment is feasible and safe. The study is small and ea…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: EARLY_PHASE1 • Sponsor: Lachelle D. Weeks, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Vitamin c boost: could high doses help chemo fight tough blood cancers?
Disease control Recruiting nowThis study tests whether adding high-dose vitamin C (ascorbic acid) to standard chemotherapy can help kill cancer cells better in people with certain blood cancers that have returned or not responded to treatment. It includes adults with relapsed or refractory lymphoma, clonal cy…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could cholesterol drugs fight blood cancer? small study tests idea
Disease control Recruiting nowThis study tests whether statins, common cholesterol-lowering drugs, can reduce inflammation and slow the progression of two blood disorders: CCUS and lower-risk MDS. These conditions can lead to more serious blood cancers or heart problems, and there are no approved treatments t…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug aimed at genetic weakness in blood disorders
Disease control Recruiting nowThis study tests a drug called olutasidenib in people with certain early blood conditions (CCUS, lower-risk MDS, or CMML) that have a specific IDH1 gene change. The goal is to see if the drug can control the disease and is safe. About 15 participants will take the drug and be mon…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Anti-Inflammatory drug could stop blood cancer before it starts
Prevention Recruiting nowThis phase II trial tests whether canakinumab, a drug that reduces inflammation, can prevent blood cancer in people with CCUS—a condition where low blood counts and genetic mutations raise cancer risk. About 110 adults with high-risk CCUS will receive either canakinumab or a plac…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
Turmeric compound tested to tame blood cancer symptoms
Symptom relief Recruiting nowThis phase 2 trial tests whether a curcumin supplement (C3 complex with piperine) can reduce inflammation and improve symptoms in people with certain blood disorders, including CCUS, low-risk MDS, and MPNs. Thirty participants will receive either curcumin or a placebo for 12 mont…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can a simple blood test predict leukemia risk after cancer therapy?
Knowledge-focused Recruiting nowThis study investigates clonal hematopoiesis (CH) — small mutations in blood cells that can arise naturally or after cancer treatment — in adults receiving chemotherapy or radiation for solid tumors like breast, lung, or colorectal cancer. Researchers will collect blood, saliva, …
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
10-Year study tracks hidden DNA changes that raise risk of cancer and heart disease
Knowledge-focused Recruiting nowThis study follows 306 adults with certain DNA changes in their blood cells (called CHIP or CCUS) to see how these changes affect health over time. Researchers want to learn if these changes increase the risk of blood cancers or heart problems. Participants will have yearly check…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can we predict blood cancer in ovarian cancer survivors?
Knowledge-focused Recruiting nowThis study follows 2,000 people who have had ovarian or other solid cancers to learn why some later develop blood cancers like leukemia. Researchers will look at genetic changes in blood cells and treatment history to identify risk factors. No new treatments are being tested—the …
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New study uses DNA tests to catch blood cancers before they start
Knowledge-focused Recruiting nowThis study is looking at 2,000 people who have early warning signs of blood cancers or bone marrow failure. Researchers use a special genetic test (next generation sequencing) to find changes in cancer-related genes. The goal is to better understand who is at risk and to catch th…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC